dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Birth Weight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bard, H; Conway, B; Courtney, SE; Long, W; McMillan, D; Sauve, R; Thompson, T; Walter, D | 1 |
| Bourchier, D; Broadbent, R; Darlow, B; Knight, D; Selby, R; Wach, R | 1 |
| Cotton, RB; Law, AB; Lindstrom, DP; Olsson, T; Parker, RA; Sandberg, K; Silberberg, AR; Sundell, HW | 1 |
| Bastida, J; Del Barco, M; Grandzoto, J; Hayward, PE; Margotto, P; Martell, M; Peña, J; Rossello, JD; Villanueva, D | 1 |
| Hamdan, AH; Shaw, NJ | 1 |
| Kempley, ST; Murdoch, E | 1 |
| Ashton, MR; Austin, NC; Hall, MA; Normand, IC; Postle, AD; Smith, DE | 1 |
| Bard, H; Chernick, V; Corbet, A; Cotton, R; Courtney, S; Long, W; McGuiness, G; Smyth, J; Walter, D; Watts, J | 1 |
| Ballard, RA; Clements, JA; Heilbron, DC; Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, SH; Tooley, WH; Wakeley, A | 1 |
9 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Birth Weight
| Article | Year |
|---|---|
Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Topics: Air; Birth Weight; Child Development; Double-Blind Method; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Health Status; Humans; Infant, Newborn; Male; Nervous System Diseases; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Psychomotor Performance; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Retinopathy of Prematurity | 1995 |
Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
Topics: Birth Weight; Cerebral Hemorrhage; Cohort Studies; Cost of Illness; Drug Combinations; Fatty Alcohols; Female; Hospital Mortality; Humans; Infant, Newborn; Infant, Premature; Male; New Zealand; Oxygen Inhalation Therapy; Phosphorylcholine; Polyethylene Glycols; Prenatal Care; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Steroids; Survival Rate; Ultrasonography | 1994 |
The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
Topics: Biological Products; Birth Weight; Drug Combinations; Fatty Alcohols; Female; Gestational Age; Humans; Hyaline Membrane Disease; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Premature; Male; Oxygen; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Function Tests | 1993 |
Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
Topics: Birth Weight; Drug Combinations; Fatty Alcohols; Female; Humans; Hyaline Membrane Disease; Infant Mortality; Infant, Newborn; Infant, Premature; Intensive Care, Neonatal; Latin America; Male; Phosphorylcholine; Polyethylene Glycols; Prospective Studies; Pulmonary Surfactants; Retrospective Studies | 1997 |
Changes in pulmonary artery pressure during the acute phase of respiratory distress syndrome treated with three different types of surfactant.
Topics: Acceleration; Biological Products; Birth Weight; Blood Pressure; Cardiac Output; Drug Combinations; Fatty Alcohols; Humans; Infant, Newborn; Inhalation; Oxygen; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pressure; Pulmonary Artery; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Ultrasonography, Doppler; Ventricular Function, Right | 1998 |
The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
Topics: Biological Products; Birth Weight; Diuresis; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Infant, Premature; London; Phospholipids; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Time Factors; Treatment Outcome; Water-Electrolyte Balance | 2000 |
Turnover of exogenous artificial surfactant.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Birth Weight; Chromatography, High Pressure Liquid; Drug Combinations; Fatty Alcohols; Gestational Age; Humans; Infant, Newborn; Intubation, Intratracheal; Phosphatidylcholines; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn | 1992 |
A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Topics: Birth Weight; Bronchopulmonary Dysplasia; Child; Drug Combinations; Fatty Alcohols; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature, Diseases; Male; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Ventilator Weaning | 1991 |
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membrane Disease; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Recurrence; Regression Analysis; Respiration, Artificial; Time Factors | 1991 |